The Journal: plain-language pieces translating real psychedelic science. What the research actually says, who's doing it, and why we fund it. No hype, no noise.
Trees feeding their offspring through fungal networks is one of the best-loved ideas in popular science. Three ecologists checked the three central claims. One of them has no published evidence at all.
Read the field note
Research Watch
At six months, 40.5% of the psilocybin group were verified as still not smoking, against 10.0% on patches. Both groups also had 13 weeks of therapy,...
By Stem & Cap
Research Watch
The largest trial of its kind gave 233 people with treatment-resistant depression a single dose. The three-week result was real. The definition of remission was narrower...
By Stem & Cap
Mind & Mood
The most mythologised part of the experience, described in the careful language researchers actually use, including what they measure and what they still can't claim.
By Stem & Cap
Research Watch
The best-controlled studies keep finding the same thing, and it isn't what the internet says. Placebo is doing more work here than most people want to...
By Stem & Cap
The Cause
Our pledge in full: what 10% of a sale is, how we choose who receives it, and how to check a research charity before anyone gives...
By Stem & Cap
The Science
Everyone says psychedelics rewire the brain. Here is what that means at the level of a single synapse, what has only been shown in mice, and...
By Stem & Cap
Mind & Mood
Two words that sound like counterculture shorthand describe the most rigorous part of a clinical psychedelic session: preparation, the room, trained guides, and the weeks afterwards.
By Stem & Cap
Research Watch
Psilocybin therapy has cleared its first phase 3 hurdles. The effect is real, smaller than phase 2 suggested, and none of it is peer-reviewed yet.
By Stem & Cap
The Science
The brain circuit that narrates your life, why an overactive one tracks with rumination, and what the imaging actually shows under psilocybin.
By Stem & Cap
We're still writing this one. Try another topic.
The newsletter
One considered piece every week or two. Real science, plainly told, and first look at each new drop.
No noise, no selling your data. Unsubscribe anytime.
